HC Surgical Specialists Management

Management criteria checks 2/4

HC Surgical Specialists' CEO is Sieu Min Heah, appointed in Sep 2015, has a tenure of 8.58 years. directly owns 41.6% of the company’s shares, worth SGD16.64M. The average tenure of the management team and the board of directors is 5 years and 7.6 years respectively.

Key information

Sieu Min Heah

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	8.6yrs
CEO ownership	41.6%
Management average tenure	5yrs
Board average tenure	7.6yrs

Recent management updates

Recent updates

CEO

Sieu Min Heah (59 yo)

8.6yrs

Tenure

Dr. Sieu Min Heah, MB BCh, FRCSEd (General Surgery), FAMS General Surgery, has been Chief Executive Officer and Executive Director of HC Surgical Specialists Limited since September 1, 2015.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Sieu Min Heah	CEO & Executive Director	8.6yrs	no data	41.6% SGD 16.6m
Soo Ling Ong	Chief Financial Officer	8.2yrs	no data	no data
Josephine Tio Melissa	Chief Operating Officer	1.9yrs	no data	no data
Kok Hoong Chia	Medical Director & Executive Director	no data	no data	22.6% SGD 9.0m
Gary Ng	Head of the Internal Audit	no data	no data	no data
Hui Theng Lee	Chief Nursing Officer	less than a year	no data	0.065% SGD 26.0k
Moi Heyang Lin	Joint Company Secretary	no data	no data	no data
Pei Chan Tang	Joint Company Secretary	no data	no data	no data

5.0yrs

Average Tenure

59yo

Average Age

Experienced Management: 1B1's management team is seasoned and experienced (5 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Sieu Min Heah	CEO & Executive Director	8.6yrs	no data	41.6% SGD 16.6m
Kok Hoong Chia	Medical Director & Executive Director	8.6yrs	no data	22.6% SGD 9.0m
Seng Soon Ooi	Independent Non-Executive Director	7.6yrs	no data	no data
Weng Hoe Chong	Independent Non-Executive Chairman	7.6yrs	no data	0.11% SGD 43.6k
Chye Lai Lim	Non-Independent Non-Executive Director	7.6yrs	no data	0.16% SGD 65.0k

7.6yrs

Average Tenure

59yo

Average Age

Experienced Board: 1B1's board of directors are considered experienced (7.6 years average tenure).

HC Surgical Specialists Management

Management criteria checks 2/4

Key information

Recent management updates

Insufficient new directors

Insufficient new directors

HC Surgical Specialists Limited, Annual General Meeting, Sep 26, 2023

Insufficient new directors

Insufficient new directors

Insufficient new directors

Recent updates

Insufficient new directors

First half 2024 earnings released: EPS: S$0.023 (vs S$0.014 in 1H 2023)

HC Surgical Specialists Limited Declares Interim Dividend for the Financial Year Ending 31 May 2024, Payable on 13 March 2024

HC Surgical Specialists Limited Declares Interim Dividend, Payable on 13 March 2024

Insufficient new directors

Upcoming dividend of S$0.01 per share at 6.3% yield

HC Surgical Specialists Limited Approves A Final Dividend for the Financial Year Ended 31 May 2023

New minor risk - Shareholder dilution

HC Surgical Specialists Limited Proposes Final Dividend for the Financial Year Ended 31 May 2023

HC Surgical Specialists Limited, Annual General Meeting, Sep 26, 2023

Full year 2023 earnings released: EPS: S$0.019 (vs S$0.043 in FY 2022)

New minor risk - Financial data availability

Insufficient new directors

Insufficient new directors

Upcoming dividend of S$0.01 per share at 4.9% yield

HC Surgical Specialists Limited Announces Interim Dividend for the Financial Year Ending 31 May 2023, Payable on 13 March 2023

First half 2023 earnings released

Insufficient new directors

Insufficient new directors

Upcoming dividend of S$0.012 per share

HC Surgical Specialists Limited Approves Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 31 May 2022

Now 21% undervalued after recent price drop

HC Surgical Specialists Limited, Annual General Meeting, Sep 27, 2022

Full year 2022 earnings released: EPS: S$0.043 (vs S$0.053 in FY 2021)

HC Surgical Specialists Limited Recommends Final Dividend for the Financial Year Ended May 31, 2022

HC Surgical Specialists Limited Appoints Melissa Josephine Tio @ Melissa Josephine Susantio as Chief Operating Officer, Effective 1 May 2022

Insufficient new directors

HC Surgical Specialists Limited Announces Resignation of Chief Operating Officer, Ouyang Yuxia, Connie, Effective 30 April 2022

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of S$0.023 per share

Upcoming dividend of S$0.023 per share

Full year 2021 earnings released: EPS S$0.053 (vs S$0.027 in FY 2020)

HC Surgical Specialists Limited Announces That the Court of Appeal Dismissed

First half 2021 earnings released: EPS S$0.033

New 90-day high: S$0.42

HC Surgical Specialists Limited (Catalist:1B1) agreed to acquire remaining 30% stake in Julian Ong Endoscopy & Surgery (Pte Ltd).

HC Surgical Specialists Limited (Catalist:1B1) acquired 20% stake in Healthcare Essentials Pte. Ltd. from Lim Chye Lai, Gjan for SGD 0.18 million.

HC Surgical Specialists Provides Cashless and Convenient Healthcare Services to Eligible 1 Customers of Prudential Singapore

New 90-day high: S$0.35

New 90-day high - S$0.34

Full year earnings released - EPS S$0.023

New 90-day low - S$0.29

HC Surgical Specialists Limited completed the acquisition of additional 19% stake in Julian Ong Endoscopy & Surgery (Pte Ltd) from Julian Ong Surgery Pte. Ltd. for $3.8 million.

HC Surgical Specialists Limited (Catalist:1B1) completed the acquisition of additional 19% stake in Julian Ong Endoscopy & Surgery Pte. Ltd from Julian Ong Surgery Pte. Ltd.

CEO

Tenure

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age